The Georgetown-Howard Universities Center for Clinical and Translational Science is delighted to sponsor and support a three-day power and sample size workshop. The short course, taught by Keith E. Muller, Ph.D., professor in the University of Florida College of Medicine, and Deborah H. Glueck, Ph.D., associate professor in the University of Colorado School of Public Health, will give scientists training for selecting a valid sample size for longitudinal and multilevel study designs. The workshop is accessible to all, from graduate students to senior researchers, and requires only basic statistical background.
Course Objectives:
- Understand a framework and strategy for study planning
- Write study aims as testable hypotheses
- Describe a longitudinal and multilevel study design
- Write a statistical analysis plan
- Ensure sufficient sample size for subgroups for studies of disparities
- Demonstrate the feasibility of recruitment
- Describe expected missing data and dropout
- Write a power and sample size analysis that is aligned with the planned statistical analysis
- Write the design, analysis, power and sample size sections for a grant
August 28-30, 2017
9:00 am to 5:00 pm
Louis Stokes Health Sciences Library, Room 138
Howard University
501 W Street NW, Washington, D.C., 20059
To learn more and register, visit the website.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Materials for the course were developed with support from NIH OBSSR and NIGMS via 1R25GM111901-01, “A Master Course on Power for Multilevel and Longitudinal Health Behavior Studies,” 08/25/2014-06/30/2018. Additional support was provided by the Center for Bioethics and Humanities of the University of Colorado Denver, the University of Florida (UF) Clinical and Translational Science Institute, the UF Department of Health Outcomes and Policy, and Federal funds (UL1TR001409) from the National Center for Advancing Translational Services (NCATS), National Institutes of Health, through the Clinical and Translational Science Awards Program (CTSA), a trademark of DHHS, part of the Roadmap Initiative, “Re-Engineering the Clinical Research Enterprise.
